Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease (Q64239248)

From Wikidata

Jump to navigation Jump to search

scholarly article by Tetsuro Tsujimoto & Hiroshi Kajio published 22 January 2019 in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Language	Label	Description	Also known as
English	Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease	scholarly article by Tetsuro Tsujimoto & Hiroshi Kajio published 22 January 2019 in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Statements

scholarly article

0 references

Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease (English)

0 references

coronary artery disease

0 references

tissue plasminogen activator

0 references

1 reference

based on heuristic

inferred from title

Tetsuro Tsujimoto

1

object named as

Tetsuro Tsujimoto

0 references

author name string

Hiroshi Kajio

2

0 references

language of work or name

0 references

publication date

22 January 2019

0 references

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

0 references

8

0 references

2

0 references

e011207

0 references

Pathophysiology of isolated systolic hypertension in elderly patients: Doppler echocardiographic insights

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired fibrinolysis in coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor in the blood of patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes mellitus: a hypercoagulable state

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fibrinolysis system: regulation of activity and physiologic functions of its main components

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes mellitus as a prothrombotic condition

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of therapies for type 2 diabetes and coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and [...]

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of diabetes among men and women in China

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes).

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PAI-1 and diabetes: a journey from the bench to the bedside

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Everolimus-eluting versus sirolimus-eluting coronary stents in patients with and without diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: results from the ATHEROREMO-IVUS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fourth Universal Definition of Myocardial Infarction (2018)

1 reference

https://pubmed.ncbi.nlm.nih.gov/30646801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1161/JAHA.118.011207

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64239248&oldid=2086987730"